
Lukem Pharmaceuticals Private Limited
About Lukem Pharmaceuticals Private Limited
Data last updated:
Lukem Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 28 August 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24100BR2009PTC014796. Its GSTIN is 10AABCL6707D1Z5 (Bihar).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Bipul Kumar and Abhishek Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C/O Sushil Kumar Indira Nagar Road No. 5A Postal Park, Patna, Bihar, India – 800001.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.73 Lakh, a decline of 30% compared to the previous year. For the same year it recorded a net loss of ₹1.46 Lakh (net margin -13.6%) and EBITDA of -₹1.92 Lakh (EBITDA margin -17.8%). Revenue has declined at a compounded annual rate (CAGR) of 19% over three years and 14% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Lukem Pharmaceuticals Private Limited's registered office is in Patna, Bihar. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressC/O Sushil Kumar Indira Nagar Road No. 5A Postal Park, Patna, Bihar, India – 800001
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Lukem Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Lukem Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Lukem Pharmaceuticals Private Limited, buy the company report.
Financials of Lukem Pharmaceuticals Private Limited
FY 2025 filings availableLukem Pharmaceuticals Private Limited reported revenue of ₹10.73 Lakh (down 30% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 14% over five years, including a 30% fall in the latest year. EBITDA fell 471% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹1.92 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.46 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -17.8% | ||||
| Net Profit Margin | -13.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Lukem Pharmaceuticals Private Limited, buy the company report.
Board of directors of Lukem Pharmaceuticals Private Limited
Lukem Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bipul Kumar | Director | 28 Aug 2009 | 17 Years 1 Months | Current |
| Abhishek Sharma | Director | 28 Aug 2009 | 17 Years 1 Months | Current |
Peer comparison
Lukem Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Medstream Pharmaceuticals (India) Private Limited | ₹10.76 Lakh (FY 2025) | 4.0% | Mumbai, Maharashtra, India | |||
| Ak Pharmaceuticals Private Limited | ₹10.76 Lakh (FY 2025) | 22.0% | New Delhi, Delhi, India | |||
| Gabreal Pharmaceuticals Pvt Ltd | ₹10.73 Lakh (FY 2023) | -8.0% | Dombivli, Maharashtra, India | |||
| Lukem Pharmaceuticals Private Limitedthis company | ₹10.73 Lakh (FY 2025) | -₹1.46 Lakh | -13.6% | -30.0% | Patna, Bihar, India | |
| Shinewell Pharmaceuticals Private Limited | ₹10.69 Lakh (FY 2024) | 2.0% | Nalasopara West, Maharashtra, India |
To see the full peer comparison of Lukem Pharmaceuticals Private Limited, buy the company report.
Auditor
Lukem Pharmaceuticals Private Limited is audited by HNM& ASSOCIATES for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HNM& ASSOCIATES | FY 2017 | 014378C |
Shareholding
The shareholding of Lukem Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Lukem Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Lukem Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Lukem Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Lukem Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCL6707D1Z5 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Lukem Pharmaceuticals Private Limited, buy the company report.
Recent activity
Lukem Pharmaceuticals Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Ramakant Prasad Singh ceased to be Director on 19 May 2012.
Frequently asked questions
Lukem Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in other wholesale, within the trading industry. It was incorporated on 28 August 2009 (17+ years old) and is registered under CIN U24100BR2009PTC014796.
Lukem Pharmaceuticals has 2 current directors:
- Bipul Kumar - Director
- Abhishek Sharma - Director
The latest financial statements of Lukem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Lukem Pharmaceuticals is 10AABCL6707D1Z5, registered in Bihar.
The CIN (Corporate Identification Number) of Lukem Pharmaceuticals is U24100BR2009PTC014796. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Lukem Pharmaceuticals was incorporated on 28 August 2009, making it 17+ years old. It is registered with the Registrar of Companies, Patna.
The peers of Lukem Pharmaceuticals by revenue are Medstream Pharmaceuticals (India) Private Limited, Ak Pharmaceuticals Private Limited, Gabreal Pharmaceuticals Pvt Ltd, Shinewell Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (wholesale trading).
Ramakant Prasad Singh ceased to be Director on 19 May 2012. Sudhanshu Kumar ceased to be Director on 05 May 2010. Abhishek Sharma was appointed as Director on 28 Aug 2009. Lukem Pharmaceuticals has 4 board changes on record in total.
The registered office of Lukem Pharmaceuticals is at CO Sushil Kumar Indira Nagar Road No. 5A Postal Park, Patna, Bihar, India – 800001.
Lukem Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Lukem Pharmaceuticals is compliant as of 09 July 2026. The company is actively filing with the Registrar of Companies.